Greenleaf Trust Has $1.25 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Greenleaf Trust boosted its holdings in CME Group Inc. (NASDAQ:CME) by 7.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,362 shares of the financial services provider’s stock after purchasing an additional 356 shares during the period. Greenleaf Trust’s holdings in CME Group were worth $1,245,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Czech National Bank increased its holdings in CME Group by 6.9% during the third quarter. Czech National Bank now owns 73,355 shares of the financial services provider’s stock worth $16,186,000 after buying an additional 4,742 shares during the last quarter. GAMMA Investing LLC raised its holdings in CME Group by 27.1% in the 3rd quarter. GAMMA Investing LLC now owns 4,131 shares of the financial services provider’s stock valued at $912,000 after acquiring an additional 881 shares during the period. Miracle Mile Advisors LLC boosted its holdings in shares of CME Group by 18.9% during the third quarter. Miracle Mile Advisors LLC now owns 3,837 shares of the financial services provider’s stock worth $847,000 after acquiring an additional 609 shares during the period. Cohen Investment Advisors LLC bought a new stake in CME Group in the 3rd quarter valued at $369,000. Finally, Alpha Cubed Investments LLC increased its position in CME Group by 4.6% during the 3rd quarter. Alpha Cubed Investments LLC now owns 176,629 shares of the financial services provider’s stock worth $38,973,000 after buying an additional 7,784 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CME. Barclays lifted their price target on shares of CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a research report on Monday, December 9th. Redburn Atlantic cut shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Piper Sandler upped their price objective on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Finally, Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and cut their target price for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $229.27.

CME Group Price Performance

Shares of NASDAQ:CME opened at $240.65 on Tuesday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $249.02. The firm has a market capitalization of $86.72 billion, a PE ratio of 25.30, a P/E/G ratio of 5.37 and a beta of 0.57. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a 50-day moving average price of $234.73 and a two-hundred day moving average price of $222.78.

CME Group Increases Dividend

The business also recently announced a dividend, which was paid on Thursday, January 16th. Shareholders of record on Friday, December 27th were paid a $5.80 dividend. The ex-dividend date was Friday, December 27th. This is an increase from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

CME Group announced that its board has initiated a stock buyback plan on Thursday, December 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.